Healthcare

Neurotech International Ltd (ASX:NTI) has gained around 10%, reflecting renewed investor interest inbiotech micro-cap stocks. The healthcare sector is known forevent-driven rallies, where clinical developments can trigger sharp price movements.

Amplia Therapeutics Ltd (ASX:ATX) has surged over75%, making it one of the topASXhealthcare gainers.

CSL Limited (ASX:CSL) remains one of Australia’s largest and most globally recognised healthcare companies, with a strong presence in biotechnology and plasma therapeutics. As a major player in the global healthcare sector, CSL’s performance is closely monitored by investors seeking exposure to defensive growth …

Sigma Healthcare Limited (ASX:SIG) has emerged as one of the standout performers in the Australian healthcare and retail pharmacy sector, driven by strong operational execution and the strategic integration of its Chemist Warehouse (CW)partnership.

ResMed Inc. (ASX:RMD) is a global leader in sleep and respiratory care, operating at the intersection of medical devices and digital health technology. The company has built a strong reputation for innovation in treating sleep apnea and chronic respiratory conditions, supported by a rapidly …

Memphasys Ltd (ASX:MEM) ended the session unchanged at AUD 0.0050 on 20 March 2026, coinciding with the release of its latest operational update. While the share price showed no immediate reaction, the stock remains significantly lower over a longer horizon, down 16.67% over the …

Paradigm Biopharmaceuticals Ltd (ASX:PAR) is gaining renewed investor attention as it advances its late-stage clinical development program targeting osteoarthritis, one of the most prevalent chronic conditions globally. The company’s share price rose 3.85% to A$0.27, reflecting positive sentiment following updates on its ongoing Phase …